Kodiak Sciences Inc.

NASDAQ:KOD

Biotechnology

Healthcare
$97.81 -0.08%

-$0.03 today

Market cap
$6.40B
Beta
2.21
P/E (TTM)
-9.6
EPS (TTM)
-$3.73
52W Low $3.43High $47.84

Volume 0.74M

Average 1.10M

KOD EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How KOD compares with its peers on the latest reported figures

KOD Competitors Peer median
EBITDA Margin for KOD and competitors
Company Period LTM level YoY 3-year change
REGNRegeneron Pharmaceuticals, Inc.LTM Jun 202637.0% -1.1 pp-2.6 pp
BLCOBausch + Lomb CorporationLTM Jun 202613.9% +4.5 pp-5.4 pp
FDMT4D Molecular Therapeutics, Inc.LTM Mar 2026-185.2% +738962.6 pp+3203.1 pp
OCULOcular Therapeutix, Inc.LTM Mar 2026-527.0% -231.3 pp-361.8 pp
OCGNOcugen, Inc.LTM Mar 2026-1437.5% -246.2 pp+2103.9 pp
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026-3415.1% -3156.5 pp-497.7 pp
OTLKOutlook Therapeutics, Inc.LTM Mar 2026-18634.1% -28166.9 pp—
OCSOculis Holding AGLTM Mar 2026-18676.3% ——
KODKodiak Sciences Inc.FY2025— ——
BLTEBelite Bio, IncFY2025— ——
Peer median (excluding KOD) -982.2%-231.3 pp-4.0 pp

Competitors are the stored peer set for KOD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue8.71M11M25.95M26.71M0
Gross Profit(8.71M)(11M)(25.95M)(26.71M)0
Gross Margin—————
Research & Development217.34M267.59M206.3M126.1M182.37M
Selling, General & Admin41M62.79M71.02M34.05M52.02M
Operating Expenses258.34M330.38M251.37M160.14M234.39M
Depreciation & Amortization8.71M11M25.95M26.71M26.32M
EBITDA(258.26M)(322.8M)(234.53M)(149.5M)(203.65M)
EBITDA Margin—————
Operating Income(267.05M)(341.38M)(277.32M)(186.85M)(234.39M)
Operating Margin—————
Interest Income298K7.07M16.73M11.15M4.52M
Interest Expense22K18K13K00
Other Income / Expenses61K7.56M16.83M10.64M4.42M
Income Before Tax(266.99M)(333.82M)(260.49M)(176.21M)(229.97M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(266.99M)(333.82M)(260.49M)(176.21M)(229.97M)
Net Margin—————
EPS (Basic)(5.16)(6.39)(4.97)(3.35)(4.32)
EPS (Diluted)(5.16)(6.39)(4.97)(3.35)(4.32)
Weighted Avg Shares51.79M52.25M52.41M52.58M53.21M
Weighted Avg Shares (Diluted)51.79M52.25M52.41M52.58M53.21M

Kodiak Sciences Inc.

NASDAQ:KOD

Intrinsic Alpha fair value

Locked

Current Price

$97.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.